Institution
Jawaharlal Nehru University
Education•New Delhi, India•
About: Jawaharlal Nehru University is a education organization based out in New Delhi, India. It is known for research contribution in the topics: Population & Candida albicans. The organization has 6082 authors who have published 13455 publications receiving 245407 citations. The organization is also known as: JNU.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The study of the effect of various bacterial species, collected from burn wounds on the growth of Candida sp.
77 citations
••
TL;DR: It was observed that H2AX gene expression was negatively correlated with miR-24-2 expression and not in accordance with the gene copy number status, both in cell lines and in sporadic breast tumor tissues, suggesting the potentiating effect of mir- 24-2-mediated apoptotic induction in human cancer cell lines treated with anticancer drugs.
Abstract: New levels of gene regulation with microRNA (miR) and gene copy number alterations (CNAs) have been identified as playing a role in various cancers. We have previously reported that sporadic breast cancer tissues exhibit significant alteration in H2AX gene copy number. However, how CNA affects gene expression and what is the role of miR, miR-24-2, known to regulate H2AX expression, in the background of the change in copy number, are not known. Further, many miRs, including miR-24-2, are implicated as playing a role in cell proliferation and apoptosis, but their specific target genes and the pathways contributing to them remain unexplored. Changes in gene copy number and mRNA/miR expression were estimated using real-time polymerase chain reaction assays in two mammalian cell lines, MCF-7 and HeLa, and in a set of sporadic breast cancer tissues. In silico analysis was performed to find the putative target for miR-24-2. MCF-7 cells were transfected with precursor miR-24-2 oligonucleotides, and the gene expression levels of BRCA1, BRCA2, ATM, MDM2, TP53, CHEK2, CYT-C, BCL-2, H2AFX and P21 were examined using TaqMan gene expression assays. Apoptosis was measured by flow cytometric detection using annexin V dye. A luciferase assay was performed to confirm BCL-2 as a valid cellular target of miR-24-2. It was observed that H2AX gene expression was negatively correlated with miR-24-2 expression and not in accordance with the gene copy number status, both in cell lines and in sporadic breast tumor tissues. Further, the cells overexpressing miR-24-2 were observed to be hypersensitive to DNA damaging drugs, undergoing apoptotic cell death, suggesting the potentiating effect of mir-24-2-mediated apoptotic induction in human cancer cell lines treated with anticancer drugs. BCL-2 was identified as a novel cellular target of miR-24-2. mir-24-2 is capable of inducing apoptosis by modulating different apoptotic pathways and targeting BCL-2, an antiapoptotic gene. The study suggests that miR-24-2 is more effective in controlling H2AX gene expression, regardless of the change in gene copy number. Further, the study indicates that combination therapy with miR-24-2 along with an anticancer drug such as cisplatin could provide a new avenue in cancer therapy for patients with tumors otherwise resistant to drugs.
77 citations
••
TL;DR: An enthralling and exceptionally close race to garner the top position within the electron deficient molecules unfolds, which has immense implications with regard to stability and potential applications.
Abstract: Arylenediimides are inherently electron deficient and provide enormous opportunities to conjugate electron withdrawing substituents in different regions of the π-scaffold. This review article highlights the gradual emergence of diverse molecular design principles to realize exceptionally electron deficient arylenediimide molecules. Interestingly, non-conventional electron withdrawing substituents allow the realization of some of the strongest electron acceptors known from this class of molecules. Thus, an enthralling and exceptionally close race to garner the top position within the electron deficient molecules unfolds, which has immense implications with regard to stability and potential applications.
77 citations
••
TL;DR: Evl was not more effective than the β-blocker propranolol for the secondary prophylaxis of variceal bleeding in patients with NCPH and rates of recurrence of bleeding were similar between the groups.
77 citations
••
TL;DR: Rhamnolipids (RLs) are surface-active compounds and belong to the class of glycolipid biosurfactants, mainly produced from Pseudomonas aeruginosa as discussed by the authors.
Abstract: Rhamnolipids (RLs) are surface-active compounds and belong to the class of glycolipid biosurfactants, mainly produced from Pseudomonas aeruginosa. Due to their non-toxicity, high biodegradability, low surface tension and minimum inhibitory concentration values, they have gained attention in various sectors like food, healthcare, pharmaceutical and petrochemicals. The ecofriendly biological properties of rhamnolipids make them potent materials to be used in therapeutic applications. RLs are also known to induce apoptosis and thus, able to inhibit proliferation of cancer cells. RLs can also act as immunomodulators to regulate the humoral and cellular immune systems. Regarding their antimicrobial property, they lower the surface hydrophobicity, destruct the cytoplasmic membrane and lower the critical micelle concentration to kill the bacterial cells either alone or in combination with nisin possibly due to their role in modulating outer membrane protein. RLs are also involved in the synthesis of nanoparticles for in vivo drug delivery. In relation to economic benefits, the post-harvest decay of food can be decreased by RLs because they prevent the mycelium growth, spore germination of fungi and inhibit the emergence of biofilm formation on food. The present review focuses on the potential uses of RLs in cosmetic, pharmaceutical, food and health-care industries as the potent therapeutic agents.
77 citations
Authors
Showing all 6255 results
Name | H-index | Papers | Citations |
---|---|---|---|
Ashok Kumar | 151 | 5654 | 164086 |
Rajesh Kumar | 149 | 4439 | 140830 |
Sanjay Gupta | 99 | 902 | 35039 |
Rakesh Kumar | 91 | 1959 | 39017 |
Praveen Kumar | 88 | 1339 | 35718 |
Rajendra Prasad | 86 | 945 | 29526 |
Mukesh K. Jain | 85 | 539 | 27485 |
Shiv Kumar Sarin | 84 | 740 | 28368 |
Gaurav Sharma | 82 | 1244 | 31482 |
Santosh Kumar | 80 | 1196 | 29391 |
Dinesh Mohan | 79 | 283 | 35775 |
Govindjee | 76 | 426 | 21800 |
Dipak K. Das | 75 | 327 | 17708 |
Amit Verma | 70 | 497 | 16162 |
Manoj Kumar | 65 | 408 | 16838 |